摘要
目的 探讨不同性别甲亢患者心理状态及针对性护理的临床干预效果。方法 择取我院2018年10月—2020年10月收治的120例甲亢患者作为研究对象,给予针对性护理,采用SCL-90量表于患者入院初期以及护理干预1个疗程后调查患者的心理状态,并对数据进行统计分析。结果 入院初期,男性患者的偏执症状、强迫症状及敌对症状得分高于女性,而恐怖症状得分低于女性,且差异均有统计学意义(均P<0.05)。干预后,男性患者偏执症状、强迫症状、恐怖症状、焦虑症状、敌对症状、抑郁症状得分及SCL-90总分均低于干预前,且差异均有统计学意义(均P<0.05);女性患者强迫症状、恐怖症状、焦虑症状、敌对症状、抑郁症状、躯体化得分及SCL-90总分均低于干预前,且差异均有统计学意义(均P<0.05)。结论 不同性别甲亢患者的心理状态不同,在此基础上对患者采取针对性护理,可以有效改善患者的心理状态,提高患者的治疗效果,临床价值明显。
Objective To investigate the psychological status of patients with hyperthyroidism of different genders and the clinical effect of targeted care. Methods A total of 120 patients with hyperthyroidism admitted to our hospital from October 2018 to October 2020 were selected as the study subjects, who received targeted care. The symptom checklist 90(SCL-90) scale was used to investigate the psychological status of the patients at the early stage of admission and after one course of nursing intervention. The data were statistically analyzed. Results At the early stage of admission, the scores of paranoid, obsessive-compulsive, and hostile symptoms in male patients were significantly higher than those in female patients, while the scores of phobic symptoms were significantly lower than those in female patients(all P<0.05). After the intervention, the scores of paranoid, obsessive-compulsive, phobic symptoms, anxiety, hostile, and depressive symptoms, and total SCL-90 scores in male patients were significantly lower than those before the intervention(all P<0.05). The scores of obsessivecompulsive, phobic, anxiety, hostile, and depressive symptoms, somatization, and total SCL-90 scores in female patients were significantly lower than those before the intervention(all P<0.05). Conclusion The psychological status of patients with hyperthyroidism of different genders remains diversified. It is necessary to take targeted care for these patients, which can effectively ameliorate their psychological status and improve therapeutic effects, with marked clinical value.
作者
张芸
刘雅静
陈慧芳
Zhang Yun;Liu Yajing;Chen Huifang(Endocrinology and Metabolism Department,The First People's Hospital of Pingdingshan,pingdingshan Henan 467000,China)
出处
《保健医学研究与实践》
2022年第9期89-92,共4页
Health Medicine Research and Practice
基金
河南省医学科技攻关计划项目(201802156)。
